Description of Research Expertise

I have a particular interest in the complementary role of radionuclide molecular imaging techniques and tissue characterization with contrast-enhanced cardiac magnetic resonance imaging for sub-clinical detection, phenotyping, diagnosis, and risk stratification of individuals with various forms of cardiomyopathy.

Selected Publications

Bravo PE, Vita TS, Taqueti V, Veillet-Chowdhury M, Steigner M, Skali H, Dorbala S, Di Carli MF, Blankstein R.: Detection of Myocardial Inflammation by T2-weighted Imaging on Cardiac MRI versus FDG PET Among Patients with Suspected Cardiac Sarcoidosis. 22nd Annual Scientific Session of the American Society of Nuclear Cardiology : 2017.

Bravo PE, Fujijura K, Kijewski MF, Jacob S, Sticka W, Dubey S, Belanger A, Park M, Di Carli MF, Falk RH, Dorbala S.: Apical Sparing of Longitudinal Strain Cannot be Explained by Regional Differences in Florbetapir Retention in Cardiac Amyloidosis. ASNC, 22nd Annual Scientific Session. 22nd Annual Scientific Session of the American Society of Nuclear Cardiology : 2017.

Bravo PE, Raghu G, Rosenthal DG, Elman S, Petek BJ, Soine LA, Maki JH, Branch KR, Masri SC, Patton KK, Caldwell JH, Krieger EV: Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging International Journal of Cardiology 15 (241): 457-462,2017.

Gupta A, Taqueti VR, van de Hoef TP, Bajaj NS, Bravo PE, Murthy VL, Osborne MT, Seidelmann SB, Vita TS, Bibbo CF, Harrington M, Hainer J, Rimoldi O, Dorbala S, Bhatt DL, Blankstein R, Camici PG, Di Carli MF: Integrated Non-invasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients with Stable Coronary Artery Disease Circulation 136 (24): 2325-2336,2017.

Bravo PE, Di Carli MF, Dorbala S: Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies Heart Failure Reviews 22 (4): 455-464,2017.

Bravo PE, Dorbala S.: Targeted Nuclear Imaging Probes for Cardiac Amyloidosis. Current Cardiology Reports 19 (7): 59,2017.

Bravo PE, Taqueti VR: Cardiac MRI vs. PET for the Evaluation of Cardiac Sarcoidosis: Consider MRI First American College of Cardiology : 2017.

Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP: Apparent Left Ventricular Cavity Dilatation during PET/CT in Hypertrophic Cardiomyopathy: Clinical Predictors and Potential Mechanisms Journal of Nuclear Cardiology 23 (6): 1304-1314,2016.

Seidelmann SB, Claggett B, Bravo PE, Gupta A, Farhad H, Klein BE, Klein, R, Di Carli MF, Solomon SD: Retinal Vessel Calibers in Predicting Longterm Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study Circulation 134 (18): 1328-1338,2016.

Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti V, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R.: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity J Nucl Cardiol 25 (4): 1136-1146,2016.

View all publications

Academic Contact Information

Hospital of University of Pennsylvania
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Phone: 215-220-9494